republic-os/legislation/us/states/va/2024/hb-1187.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Xylazine; penalty for manufacturing, selling, etc., for human consumption.	Xylazine; manufacturing; selling; giving; distributing; possessing; veterinary use exemption; penalties. Provides that any person who knowingly manufactures, sells, gives, distributes, or possesses with the intent to manufacture, sell, give, or distribute the substance xylazine, when intended for human consumption, is guilty of a Class 5 felony. Under the bill, any person who knowingly possesses xylazine, when intended for human consumption, is guilty of a Class 1 misdemeanor. Under the bill, it is not an offense to (i) manufacture xylazine for legitimate veterinary use; (ii) distribute or sell xylazine for authorized veterinary use; (iii) possess, administer, prescribe, or dispense xylazine in good faith for use by animals within the course of legitimate veterinary practice; or (iv) possess or administer xylazine pursuant to a valid prescription from a licensed veterinarian. This bill is identical to SB 614.	us/states/va	Virginia General Assembly	2024	HB 1187	Virginia HB 1187 (2024)	bill		enacted	M. Keith Hodges	4	34	7	2024-01-10	2024-04-04	openstates	ocd-bill/614a6add-ca06-4b87-970d-77979fc28fa9	https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+HB1187	9fb32c294597590e44a56197d9466eebcc13b55aa9f55a898f07cbd135d62dea	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-va

Virginia HB 1187 (2024) — Xylazine; penalty for manufacturing, selling, etc., for human consumption.

Xylazine; manufacturing; selling; giving; distributing; possessing; veterinary use exemption; penalties. Provides that any person who knowingly manufactures, sells, gives, distributes, or possesses with the intent to manufacture, sell, give, or distribute the substance xylazine, when intended for human consumption, is guilty of a Class 5 felony. Under the bill, any person who knowingly possesses xylazine, when intended for human consumption, is guilty of a Class 1 misdemeanor. Under the bill, it is not an offense to (i) manufacture xylazine for legitimate veterinary use; (ii) distribute or sell xylazine for authorized veterinary use; (iii) possess, administer, prescribe, or dispense xylazine in good faith for use by animals within the course of legitimate veterinary practice; or (iv) possess or administer xylazine pursuant to a valid prescription from a licensed veterinarian. This bill is identical to SB 614.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. CHAP0472 (committee substitute) — source
2. Committee substitute printed 24106501D-H1 (committee substitute) — source
3. HB1187ER (committee substitute) — source
4. Prefiled and ordered printed; offered 01/10/24 24104644D (committee substitute) — source

Votes

• Reported from Courts of Justice with substitute (22-Y 0-N) — 22–0 (pass) · lower
• Passed Senate (40-Y 0-N) — 40–0 (pass) · upper
• Reported from Courts of Justice (9-Y 0-N) — 9–0 (pass) · upper
• Reported from Finance and Appropriations (15-Y 0-N) — 15–0 (pass) · upper
• Subcommittee recommends reporting with substitute (8-Y 0-N) — 8–0 (pass) · lower
• Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
• VOTE: Block Vote Passage (99-Y 0-N) — 98–0 (pass) · lower

Sponsors

• M. Keith Hodges — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2024-01-10 Prefiled and ordered printed; offered 01/10/24 24104644D filing, introduction
• 2024-01-10 Impact statement from VCSC (HB1187)
• 2024-01-10 Referred to Committee for Courts of Justice referral-committee
• 2024-01-24 Impact statement from DPB (HB1187)
• 2024-01-26 Assigned Courts sub: Criminal referral-committee
• 2024-02-02 House subcommittee amendments and substitutes offered
• 2024-02-02 Subcommittee recommends reporting with substitute (8-Y 0-N) substitution
• 2024-02-07 Reported from Courts of Justice with substitute (22-Y 0-N) committee-passage
• 2024-02-07 Committee substitute printed 24106501D-H1 substitution
• 2024-02-08 Impact statement from VCSC (HB1187H1)
• 2024-02-09 Impact statement from DPB (HB1187H1)
• 2024-02-09 Read first time reading-1
• 2024-02-12 Read second time reading-2
• 2024-02-12 Committee substitute agreed to 24106501D-H1 substitution
• 2024-02-12 Engrossed by House - committee substitute HB1187H1 substitution
• 2024-02-13 Read third time and passed House BLOCK VOTE (99-Y 0-N) passage, reading-3
• 2024-02-13 VOTE: Block Vote Passage (99-Y 0-N) passage
• 2024-02-14 Constitutional reading dispensed
• 2024-02-14 Referred to Committee for Courts of Justice referral-committee
• 2024-02-21 Reported from Courts of Justice (9-Y 0-N) committee-passage
• 2024-02-21 Rereferred to Finance and Appropriations referral-committee
• 2024-02-28 Reported from Finance and Appropriations (15-Y 0-N) committee-passage
• 2024-02-29 Constitutional reading dispensed (39-Y 0-N)
• 2024-03-01 Read third time reading-3
• 2024-03-01 Passed Senate (40-Y 0-N) passage
• 2024-03-07 Enrolled enrolled
• 2024-03-07 Bill text as passed House and Senate (HB1187ER) passage
• 2024-03-07 Impact statement from DPB (HB1187ER)
• 2024-03-07 Signed by Speaker passage
• 2024-03-08 Signed by President passage
• 2024-03-11 Enrolled Bill communicated to Governor on March 11, 2024 enrolled, executive-receipt
• 2024-03-11 Governor's Action Deadline 11:59 p.m., April 8, 2024 executive-receipt
• 2024-04-04 Approved by Governor-Chapter 472 (effective 7/1/24) executive-signature
• 2024-04-04 Acts of Assembly Chapter text (CHAP0472)

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/614a6add-ca06-4b87-970d-77979fc28fa9. Confidence: reported (aggregated from official Virginia legislature records).